Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl
Top Cited Papers
- 23 November 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 16 (4) , e265-e268
Abstract
Objectives: Buprenorphine can precipitate withdrawal in opioid-dependent persons with recent fentanyl use. However, the prevalence of this phenomenon is not clinically established. We sought to evaluate the incidence of buprenorphine-precipitated withdrawal in persons who use fentanyl. Methods: We collected self-report data on opioid withdrawal symptoms after buprenorphine use, and, as a comparator, after methadone use, in 1679 individuals seeking treatment for opioid use disorder across 49 addiction treatment centers in the United States. Results: The odds of developing severe withdrawal symptoms significantly increased when taking buprenorphine within 24 hours after fentanyl use (OR = 5.202, 95% CI = 1.979–13.675, P = 0.001), and within 24 to 48hours after fentanyl use (OR = 3.352, 95% CI =1.237–9.089, P = 0.017). As expected, patients did not report significantly higher rates of withdrawal when taking methadone after fentanyl use. Of those who waited less than 24hours after fentanyl before using buprenorphine or methadone, 22.19% (n = 152 of 685) and 11.56% (n = 23 of 199), respectively, reported severe opioid withdrawal. Conclusions: This study supports previous anecdotal reports of buprenorphine-precipitated withdrawal from fentanyl. The odds of withdrawal symptoms significantly increased when taking buprenorphine after recent (within 48 hours) fentanyl use, however, this relationship was not observed in persons taking methadone, suggesting that this effect is specific to buprenorphine. Further research is urgently needed to describe the pharmacokinetics of non-medical fentanyl use to improve buprenorphine inductions strategies.Keywords
This publication has 10 references indexed in Scilit:
- Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort AnalysisJournal of Addiction Medicine, 2021
- Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid AgonistsJournal of Addiction Medicine, 2021
- Short communication: Systematic review on effectiveness of micro-induction approaches to buprenorphine initiationAddictive Behaviors, 2021
- Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillanceDrug and Alcohol Dependence, 2020
- The dawn of a new synthetic opioid era: the need for innovative interventionsAddiction, 2020
- Protracted renal clearance of fentanyl in persons with opioid use disorderDrug and Alcohol Dependence, 2020
- Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/NaloxoneThe American Journal on Addictions, 2020
- “Everything is not right anymore”: Buprenorphine experiences in an era of illicit fentanylInternational Journal of Drug Policy, 2019
- What should clinicians do as fentanyl replaces heroin?Addiction, 2019
- Buprenorphine: how to use it rightDrug and Alcohol Dependence, 2003